Shanghai Shen Lian Biomedical Corporation (688098.SS)
CNY 5.89
(0.68%)
CNY 5.89
(0.68%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.59 Billion CNY | -0.69% |
| 2022 | 1.6 Billion CNY | 0.41% |
| 2021 | 1.59 Billion CNY | 5.55% |
| 2020 | 1.51 Billion CNY | 4.62% |
| 2019 | 1.44 Billion CNY | 42.89% |
| 2018 | 1.01 Billion CNY | 46.36% |
| 2017 | 692.19 Million CNY | 13.89% |
| 2016 | 607.79 Million CNY | 23.96% |
| 2015 | 490.31 Million CNY | -7.29% |
| 2014 | 528.89 Million CNY | -0.5% |
| 2013 | 531.52 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.58 Billion CNY | 1.6% |
| 2024 Q2 | 1.55 Billion CNY | -2.32% |
| 2024 Q1 | 1.59 Billion CNY | 0.01% |
| 2023 Q4 | 1.59 Billion CNY | -1.08% |
| 2023 FY | 1.59 Billion CNY | -0.69% |
| 2023 Q3 | 1.61 Billion CNY | 3.78% |
| 2023 Q1 | 1.6 Billion CNY | -0.31% |
| 2023 Q2 | 1.55 Billion CNY | -2.97% |
| 2022 Q2 | 1.57 Billion CNY | -2.23% |
| 2022 FY | 1.6 Billion CNY | 0.41% |
| 2022 Q1 | 1.61 Billion CNY | 0.99% |
| 2022 Q4 | 1.6 Billion CNY | -2.19% |
| 2022 Q3 | 1.64 Billion CNY | 3.97% |
| 2021 Q2 | 1.52 Billion CNY | -0.33% |
| 2021 Q3 | 1.61 Billion CNY | 5.69% |
| 2021 Q4 | 1.59 Billion CNY | -0.9% |
| 2021 Q1 | 1.53 Billion CNY | 1.1% |
| 2021 FY | 1.59 Billion CNY | 5.55% |
| 2020 FY | 1.51 Billion CNY | 4.62% |
| 2020 Q4 | 1.51 Billion CNY | -2.79% |
| 2020 Q3 | 1.55 Billion CNY | 6.04% |
| 2020 Q2 | 1.46 Billion CNY | -1.11% |
| 2020 Q1 | 1.48 Billion CNY | 2.64% |
| 2019 Q4 | 1.44 Billion CNY | 38.17% |
| 2019 FY | 1.44 Billion CNY | 42.89% |
| 2019 Q2 | 990.41 Million CNY | -1.6% |
| 2019 Q3 | 1.04 Billion CNY | 5.78% |
| 2019 Q1 | 1 Billion CNY | -0.65% |
| 2018 FY | 1.01 Billion CNY | 46.36% |
| 2018 Q4 | 1.01 Billion CNY | 0.0% |
| 2017 Q1 | 636.53 Million CNY | 4.73% |
| 2017 Q4 | 692.19 Million CNY | 0.0% |
| 2017 FY | 692.19 Million CNY | 13.89% |
| 2017 Q2 | 636.53 Million CNY | 0.0% |
| 2016 Q1 | 553.93 Million CNY | 0.0% |
| 2016 Q2 | 553.93 Million CNY | 0.0% |
| 2016 Q3 | 607.79 Million CNY | 9.72% |
| 2016 Q4 | 607.79 Million CNY | 0.0% |
| 2016 FY | 607.79 Million CNY | 23.96% |
| 2015 FY | 490.31 Million CNY | -7.29% |
| 2014 FY | 528.89 Million CNY | -0.5% |
| 2013 FY | 531.52 Million CNY | 0.0% |